Antibodies that bind myostatin, compositions and methods
Disclosed is an isolated myostatin-specific antibody comprising at least one light chain and at least one heavy chain, wherein the light chain comprises a constant region and a variable region that comprises three complementarity determining regions (CDRs) and the heavy chain comprises a constant re...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
27.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed is an isolated myostatin-specific antibody comprising at least one light chain and at least one heavy chain, wherein the light chain comprises a constant region and a variable region that comprises three complementarity determining regions (CDRs) and the heavy chain comprises a constant region and a variable region that comprises three CDRs, wherein the light chain CDR1, CDR2 and CDR3 are KASQDINKYVA, YTSWLQP and LQYDNLLYT, respectively, and the heavy chain CDR1, CDR2 and CDR3 are RYWMN, XIRLKSDNYATHYAESVKG and GLDY, respectively. Also disclosed is the use of the above-described myostatin-specific antibody in the preparation of a medicament for treatment or prevention of a disease or condition associated with activity of myostatin. |
---|---|
AbstractList | Disclosed is an isolated myostatin-specific antibody comprising at least one light chain and at least one heavy chain, wherein the light chain comprises a constant region and a variable region that comprises three complementarity determining regions (CDRs) and the heavy chain comprises a constant region and a variable region that comprises three CDRs, wherein the light chain CDR1, CDR2 and CDR3 are KASQDINKYVA, YTSWLQP and LQYDNLLYT, respectively, and the heavy chain CDR1, CDR2 and CDR3 are RYWMN, XIRLKSDNYATHYAESVKG and GLDY, respectively. Also disclosed is the use of the above-described myostatin-specific antibody in the preparation of a medicament for treatment or prevention of a disease or condition associated with activity of myostatin. |
Author | HAN HQ ARORA TARUNA ZHOU XIAOLAN LU HSIENG SEN CHEN QING |
Author_xml | – fullname: HAN HQ – fullname: ZHOU XIAOLAN – fullname: LU HSIENG SEN – fullname: ARORA TARUNA – fullname: CHEN QING |
BookMark | eNrjYmDJy89L5WSwcMwryUzKT8lMLVYoyUgsUUjKzEtRyK3MLy5JLMnM01FIzs8tyC_OLMnMzytWSATJpZZk5KcU8zCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeL8oMwMLIwMzR2OCCgAaiS9D |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | NZ608206A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_NZ608206A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:47:45 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_NZ608206A3 |
Notes | Application Number: NZ20110608206 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&CC=NZ&NR=608206A |
ParticipantIDs | epo_espacenet_NZ608206A |
PublicationCentury | 2000 |
PublicationDate | 20150227 |
PublicationDateYYYYMMDD | 2015-02-27 |
PublicationDate_xml | – month: 02 year: 2015 text: 20150227 day: 27 |
PublicationDecade | 2010 |
PublicationYear | 2015 |
RelatedCompanies | AMGEN INC |
RelatedCompanies_xml | – name: AMGEN INC |
Score | 2.9797826 |
Snippet | Disclosed is an isolated myostatin-specific antibody comprising at least one light chain and at least one heavy chain, wherein the light chain comprises a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Antibodies that bind myostatin, compositions and methods |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&locale=&CC=NZ&NR=608206A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LSwMxEB5qFfWm9f0oOcieXNRss4_DIu0-KEK3RaqUXkqyZnUPZosbEf-9Sdiql95CAsNkYF7JfDMAV3dBQHNCXRsHnNg9Zf9syplnc8_hXFnEwicaOzzK3OFT72FGZi14XWFhTJ_QL9McUWlUrvRdGnu9_HvEik1tZX3DSrVV3afTMLaa7FhFNxh7VjwIk8k4HkdWFIXZ3MoeQ1e7Ore_AZs6htZN9pPngYakLP_7k3QPtiaKlJD70OKiAzvRauxaB7ZHzW-3WjaKVx-A3xeyZJUu-UPyjUqkEtoX9P5daUBQKa6RLg1f1V8hqs_MaOj6ELppMo2GtmJh8XvZRTZvWHWOoC0qwU8AFQSznBfcw4UOX5ygwLkf3DKHUZdhkp_C8RoiZ2tPzmFXy8ugs70LaMuPT36p_KtkXSObH_5Ogas |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV07T8MwED6VgigblPejZECZiACneQ0RapNGAZq0QgFVXaI4OJABpyJGiH-PbaXA0s2ypdP5pHvZ990BXNw4TpYbmakhhxhan9s_LSPY0oilE8ItYmEbAjscxWb41L-fGbMWvC6xMLJP6Jdsjsg1Kuf6zqS9Xvw9YvmytrK-wiXfqm6DxPXVJjvm0Q1CluoP3dF04k881fPceK7Gj64pXJ05WIN1S7TmFXHT81BAUhb__UmwDRtTToqyHWgR2oWOtxy71oXNqPnt5stG8epdsAeUlbgSJX8Ke8uYwhPaF-X9uxKAoJJeKqI0fFl_pWTiTI6GrvegF4wSL9Q4C-nvZdN43rCq70ObVpQcglIYCOekIBYqRPiiOwXKbeca6zgzMTLyIzhYQeR45ck5dMIkGqfju_jhBLaE7CRS2zqFNvv4JGfc1zLck3L6ATcAhJg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Antibodies+that+bind+myostatin%2C+compositions+and+methods&rft.inventor=HAN+HQ&rft.inventor=ZHOU+XIAOLAN&rft.inventor=LU+HSIENG+SEN&rft.inventor=ARORA+TARUNA&rft.inventor=CHEN+QING&rft.date=2015-02-27&rft.externalDBID=A&rft.externalDocID=NZ608206A |